{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T07:09:17Z","timestamp":1766732957189,"version":"3.44.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jns.2019.03.011","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T12:18:41Z","timestamp":1552565921000},"page":"34-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Seizures in patents with primary central nervous system lymphoma: Prevalence and associated features"],"prefix":"10.1016","volume":"400","author":[{"given":"Jonah","family":"Fox","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaun","family":"Ajinkya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Houston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Lindhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cachia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Olar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekrem","family":"Kutluay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl_4","key":"10.1016\/j.jns.2019.03.011_bb0005","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011\u20132015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro-oncology"},{"issue":"9","key":"10.1016\/j.jns.2019.03.011_bb0010","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/bjc.2011.357","article-title":"Age, gender, and racial differences in incidence and survival in primary CNS lymphoma","volume":"105","author":"Villano","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.jns.2019.03.011_bb0015","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.5858\/132.11.1830","article-title":"Primary central nervous system lymphoma","volume":"132","author":"Bhagavathi","year":"2008","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"3","key":"10.1016\/j.jns.2019.03.011_bb0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11899-014-0217-2","article-title":"Primary CNS lymphoma","volume":"9","author":"Phillips","year":"2014","journal-title":"Curr. Hematol. Malignancy Rep."},{"issue":"2","key":"10.1016\/j.jns.2019.03.011_bb0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/jjco\/hyw171","article-title":"Long-term survivors of primary central nervous system lymphoma","volume":"47","author":"Yamanaka","year":"2017","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"15_suppl","key":"10.1016\/j.jns.2019.03.011_bb0030","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1200\/jco.2015.33.15_suppl.2032","article-title":"Long-term survival in patients with primary CNS lymphoma: results from the G-PCNSL-SG1 trial","volume":"33","author":"Roth","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jns.2019.03.011_bb0035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/B978-0-12-802997-8.00016-5","article-title":"Epilepsy and brain tumors","volume":"134","author":"Englot","year":"2016","journal-title":"Handb. Clin. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2019.03.011_bb0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3171\/jns.2000.92.2.0261","article-title":"Primary intracerebral malignant lymphoma: report of 248 cases","volume":"92","author":"Bataille","year":"2000","journal-title":"J. Neurosurg."},{"issue":"Suppl","key":"10.1016\/j.jns.2019.03.011_bb0045","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1002\/ana.410230707","article-title":"Primary central nervous system lymphomas in patients with AIDS","volume":"23","author":"Rosenblum","year":"1988","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.jns.2019.03.011_bb0050","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.7326\/0003-4819-119-11-199312010-00007","article-title":"Primary central nervous system lymphoma","volume":"119","author":"Fine","year":"1993","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.jns.2019.03.011_bb0055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/archneurol.2010.3","article-title":"Primary central nervous system lymphoma","volume":"67","author":"Gerstner","year":"2010","journal-title":"Arch. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2019.03.011_bb0060","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1007\/s10072-005-0404-y","article-title":"Brain tumoral epilepsy: a review","volume":"26","author":"Riva","year":"2005","journal-title":"Neurol. Sci."},{"issue":"3","key":"10.1016\/j.jns.2019.03.011_bb0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1525-5050(02)00029-X","article-title":"The role of subcortical structures in human epilepsy","volume":"3","author":"Norden","year":"2002","journal-title":"Epilepsy Behav."},{"issue":"2","key":"10.1016\/j.jns.2019.03.011_bb0070","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11060-004-3390-7","article-title":"Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients","volume":"72","author":"Kuker","year":"2005","journal-title":"J. Neuro-Oncol."},{"issue":"2","key":"10.1016\/j.jns.2019.03.011_bb0075","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3171\/2009.2.JNS081132","article-title":"Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. Clinical article","volume":"111","author":"Chaichana","year":"2009","journal-title":"J. Neurosurg."},{"issue":"19","key":"10.1016\/j.jns.2019.03.011_bb0080","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1212\/WNL.0000000000003911","article-title":"Mutant IDH1 and seizures in patients with glioma","volume":"88","author":"Chen","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2019.03.011_bb0085","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1684\/epd.2015.0788","article-title":"Relationship between tumour location and preoperative seizure incidence in patients with gliomas: a systematic review and meta-analysis","volume":"17","author":"Su","year":"2015","journal-title":"Epileptic Disord."},{"issue":"6","key":"10.1016\/j.jns.2019.03.011_bb0090","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.hoc.2016.07.013","article-title":"The challenge of primary central nervous system lymphoma","volume":"30","author":"Carnevale","year":"2016","journal-title":"Hematol. Oncol. Clin. North Am."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19301248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19301248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:45:51Z","timestamp":1758383151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X19301248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":18,"alternative-id":["S0022510X19301248"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2019.03.011","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seizures in patents with primary central nervous system lymphoma: Prevalence and associated features","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2019.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}